CDKN1A and neoplasm: In conclusion, our findings demonstrated that HOXA5 suppressed the activity of the Wnt/β-catenin pathway and transactivated TP53 simultaneously, thus inhibiting the cell cycle progression by downregulating cyclinD1 and upregulating p21, ultimately inhibiting the neoplasia and progression in cervical cancer.